Trials / Recruiting
RecruitingNCT03409263
Austrian Registry on Transjugular Intrahepatic Portosystemic Shunts
Österreichisches Register (inklusive Biobank) Für Transjuguläre Intrahepatische Portosystemischem Shunts (TIPS): AUTIPS (AUstrian TIPS Study)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Thomas Reiberger · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Patients with TIPS will be recruited in this prospective registry study. The clinical course will be documented and biomarkers for prediction of complicatiosn will be assessed.
Detailed description
Patients with advanced chronic liver disease may develop portal hypertension, which is the main cause for most complications and deaths of patients with liver cirrhosis. Implantation of a transjugular intrahepatic portosystemic shunt (TIPS) leads to instantaneous alleviation of portal hypertension, but may cause hepatic encephalopathy. Stent grafts, as well as patient stratification and medical surveillance, have drastically improved over the past decades. However, there are few data on long-term outcome after TIPS implantation.This prospective registry study will assess the clinical course of patients after undergoing TIPS intervention and biomarkers for complications after TIPS implantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observational study | Not applicable (observational registry study) |
Timeline
- Start date
- 2018-03-28
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2018-01-24
- Last updated
- 2024-11-06
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT03409263. Inclusion in this directory is not an endorsement.